SIRT1 and autosomal recessive disease: Moreover, NAD+ augmentation significantly extends lifespan and improves healthspan by promoting mitophagy via SIRT1/SIRT2.1 in worm and mouse models of Ataxia Telangiectasia9, a rare autosomal recessive disease, and in worm and fly models of Werner syndrome65, a human premature aging disease.